Cannabis MSOs Shift Lobbying Dollars to GOP Ahead of 2026 Midterms

FEC Data Shows Sharp Rightward Shift in Industry Spending

Cannabis PACs and executives donated $8.2 million to Republican candidates and committees between January and June 2026, up from $1.9 million in the same period last year. Democratic contributions declined 12% to $11.4 million over the same window, narrowing the historical funding gap that favored Democrats by margins exceeding 7-to-1 in prior cycles.

The top five MSO-affiliated PACs—Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, and Verano—accounted for 68% of Republican-directed funds. Trulieve alone contributed $1.8 million to GOP state-party committees in Florida, Ohio, and Texas.

Curaleaf's PAC increased Republican contributions from $140,000 in H1 2025 to $1.1 million in H1 2026, a 686% jump. Green Thumb's PAC went from zero Republican donations in early 2025 to $890,000 this cycle.

State-Level Market Access Drives Strategic Realignment

Operators are chasing legislative wins in Republican trifecta states where adult-use ballot measures or legislative pathways are active. Ohio, Florida, Texas, and Montana represent the four largest near-term expansion opportunities, all controlled by GOP legislatures.

Ohio's adult-use market launched in August 2025 under a Republican governor and legislature. Florida voters will decide a constitutional amendment in November 2026 that requires 60% approval; Republican support is critical. Texas lawmakers advanced a limited medical expansion bill in the 2025 session and are expected to revisit broader reform in 2027.

Montana legalized adult-use in 2020 and is now finalizing regulations under a GOP-controlled statehouse. Operators view the state as a proving ground for rural Republican markets.

Federal Rescheduling Stalemate Pushes Focus to States

The DEA's rescheduling proposal remains stalled in administrative review with no final rule expected before 2027, according to agency statements in June. The prolonged delay has shifted industry lobbying priorities from federal reform to state-by-state market expansion.

Industry lobbyists interviewed for this story said the stalemate has forced a pragmatic pivot. One MSO government-affairs director, speaking on condition their employer not be named, said: "We can't wait for Washington. The next 10 million customers are in red states."

Federal cannabis banking legislation, the SAFER Banking Act, hasn't advanced since clearing the Senate Banking Committee in September 2025. Republican leadership in the House has declined to schedule a floor vote.

Republican Lawmakers Cite Economic and States'-Rights Arguments

GOP lawmakers who accepted industry contributions framed support for cannabis reform in economic development and federalism terms, avoiding social-justice rhetoric favored by Democrats. This rhetorical shift aligns with industry messaging that emphasizes tax revenue, job creation, and state sovereignty.

Ohio State Senator Matt Huffman, who received $25,000 from Trulieve's PAC, told the Columbus Dispatch in May that adult-use legalization was "a question of respecting voter intent and capturing tax dollars that were leaving the state." Huffman opposed legalization in 2015. He voted to implement the 2023 ballot measure.

Florida Governor Ron DeSantis, who hasn't endorsed the November 2026 ballot measure, received $50,000 in combined contributions from cannabis PACs for his 2024 presidential campaign. DeSantis hasn't returned the funds.

Democratic Contributions Decline as Priorities Shift

Cannabis industry donations to Democratic candidates fell 12% year-over-year as operators reduced spending in safe blue states with mature markets. California, Illinois, and Massachusetts—three of the five largest state markets—saw combined PAC contributions drop 28% compared to H1 2025.

Industry sources attribute the decline to market saturation and regulatory fatigue in Democratic-controlled states. California's punitive tax structure and Illinois' social-equity litigation have soured operator sentiment toward blue-state expansion.

One Democratic strategist who advises cannabis clients said the industry "got what it needed" from Democrats at the state level and is now "shopping for new partners." The strategist requested anonymity to preserve client relationships.

National Cannabis Roundtable Adds Republican Board Members

The National Cannabis Roundtable, the industry's largest federal lobbying group, added three Republican-affiliated board members in March 2026, including a former RNC finance chair. The additions followed internal debates over the group's perceived tilt toward Democratic priorities, according to two people familiar with the discussions.

The new board members are John Rakolta Jr., a Michigan construction executive and former ambassador to the UAE under President Trump; Bobbie Kilberg, a Virginia GOP donor and former White House aide; and David Urban, a lobbyist who advised Trump's 2016 campaign. All three have ties to cannabis operators through consulting agreements.

Roundtable CEO Kris Krane declined to comment on the board changes but said in a statement that the group is "committed to bipartisan advocacy that reflects the geographic and political diversity of our industry."

What Operators Are Watching in 2027 Legislative Sessions

Industry lobbyists identified five Republican-controlled states as top targets for 2027 legislative sessions: Texas, North Carolina, Kentucky, South Carolina, and Kansas. All five have active legalization bills or study commissions expected to report findings by year-end.

Texas House Bill 218 would legalize adult-use sales and establish a state regulatory framework. It has 47 co-sponsors including 12 Republicans. The bill didn't advance in 2025 but is expected to return in the 2027 session.

North Carolina's medical cannabis program, signed into law in 2023, is scheduled to begin patient sales in early 2027. Operators view the state as a bridge to adult-use legalization if the medical rollout succeeds.

• Kentucky lawmakers filed 11 cannabis-related bills in the 2026 session; none advanced but sponsor counts increased.
• South Carolina's Senate Medical Affairs Committee held its first cannabis hearing in March 2026 after a decade of inaction.
• Kansas Governor Laura Kelly, a Democrat, has endorsed legalization but faces a Republican supermajority opposed to reform. Operators are funding primary challengers to GOP holdouts.

For full background on this story, see the CannIntel topic hub on Cannabis and Republican Party Politics.